Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06197737
Other study ID # REC/MS-PT/01379
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2023
Est. completion date January 1, 2024

Study information

Verified date May 2024
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.


Description:

Chronic asthma is a complex heterogeneous disease characterized by multiple aggravating factors. Asthma is treated with two types of medicines , long term medicines and quick relieve medicine. Although the relationship between asthma and the effects of HIIT/SIT were studied in the literature, there was not one comparing the results of these aforementioned studies. The purpose of this study is to find the effects of moderate intensity interval training and sprint interval training on pat determine effects of group wise physical activity on asthma related quality of life. To determine the effects of group wise physical activity on cardiorespiratory endurance


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date January 1, 2024
Est. primary completion date January 1, 2024
Accepts healthy volunteers No
Gender All
Age group 15 Years to 25 Years
Eligibility Inclusion Criteria: - Patients having chronic asthma - Age between 15-25 years. - Participants having no dyspnea at rest . - Participants scoring 13 or less on borg scale - Exclusion Criteria - History of co-morbidities. - History of recent fractures. - Participants scoring greater than 13 on BORG scale Exclusion Criteria: - Exercise induced asthma (evaluated through BRUCE protocol). - Individuals with co-morbidities related to any neurological, cardiovascular, psychological and musculoskeletal disorders . - Patients score falling 15 or more on Borg scale.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Moderate Intensity Interval Training
Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.
Sprint Interval Training
sprint interval training in which they will do stair climbing 3 times a week with a fast pace.
pharmacological treatment
They will be on pharmacological treatment as prescribed by their pulmonologist.

Locations

Country Name City State
Pakistan Abasyn University Islamabad Federal Capital

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of change in the Inspiratory Capacity It will measured using an incentive spirometer Baseline, 8th week and then 16th week
Primary Assessment of change in the Pulmonary Function Electronic spirometer will be used to measure all the parameters of pulmonary function. Baseline, 8th week and then 16th week
Primary Assessment of change in the Oxygen saturation Measured using pulse oximeter before, during and after the intervention. Baseline, 8th week and then 16th week
Primary Assessment of change in the Rate of perceived exertion / dyspnea measured through borg scale during the assigned intervention Baseline, 8th week and then 16th week
Primary Assessment of change in the cardiovascular endurance PACER test for cardiovascular endurance test Baseline, 8th week and then 16th week
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device